يعرض 1 - 10 نتائج من 40 نتيجة بحث عن '"Androstadienes/administration & dosage"', وقت الاستعلام: 0.91s تنقيح النتائج
  1. 1

    المصدر: Ottestad, L, Fronth, L, Rajendiran, S, Hege Aksnes, L, Eikesdal, H P, Støre Blix, E & Ewertz, M 2019, ' Observational study of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer ', Acta Oncologica, vol. 58, no. 3, pp. 385-387 . https://doi.org/10.1080/0284186X.2019.1566771

    وصف الملف: application/pdf

  2. 2
  3. 3
  4. 4
  5. 5

    المصدر: Breast cancer research and treatment, 143 (3
    Breast cancer research and treatment, vol 143, iss 3
    Breast Cancer Research and Treatment

    مصطلحات موضوعية: Oncology, Aging, Cancer Research, Kaplan-Meier Estimate, law.invention, Neoplasms, Hormone-Dependent -- drug therapy -- genetics -- pathology, chemistry.chemical_compound, Metastatic disease, Breast cancer, Randomized controlled trial, Exemestane, law, Neoplasms, Receptors, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, 80 and over, Androstadienes -- administration & dosage, Progesterone, Cancer, BOLERO-2, Aged, 80 and over, Clinical Trials as Topic, Middle Aged, Clinical Trial, Receptors, Estrogen -- genetics, Breast Neoplasms -- drug therapy -- genetics -- pathology, Receptors, Estrogen, Local, 6.1 Pharmaceuticals, Female, Receptors, Progesterone, medicine.drug, Sirolimus -- administration & dosage -- analogs & derivatives, medicine.medical_specialty, Neoplasms, Hormone-Dependent, medicine.drug_class, Clinical Trials and Supportive Activities, Clinical Sciences, Oncology and Carcinogenesis, Breast Neoplasms, and over, Placebo, Disease-Free Survival, Clinical Research, Internal medicine, Neoplasm Recurrence, Local -- drug therapy -- pathology, medicine, Humans, Oncology & Carcinogenesis, Everolimus, Hormone-Dependent, Aged, Gynecology, Sirolimus, Aromatase inhibitor, business.industry, Evaluation of treatments and therapeutic interventions, medicine.disease, Estrogen, Androstadienes, Cancérologie, Neoplasm Recurrence, chemistry, Antineoplastic Combined Chemotherapy Protocols -- administration & dosage, Receptors, Progesterone -- genetics, First-line therapy, mTOR inhibition, Neoplasm Recurrence, Local, business

    وصف الملف: 1 full-text file(s): application/pdf; application/pdf

  6. 6

    المصدر: Oliver, A J, Covar, R A, Goldfrad, C H, Klein, R M, Pedersen, S, Sorkness, C A, Tomkins, S A, Villarán, C & Grigg, J 2016, ' Randomized Trial of Once-Daily Fluticasone Furoate in Children with Inadequately Controlled Asthma ', Journal of Pediatrics, vol. 178, pp. 246-253.e2 . https://doi.org/10.1016/j.jpeds.2016.08.010

    وصف الملف: application/pdf

  7. 7

    المصدر: Advances in therapy, 30 (10
    Advances in therapy, vol 30, iss 10
    Advances in Therapy

    مصطلحات موضوعية: Oncology, Aging, Lung Neoplasms, Nonsteroidal aromatase inhibitors, Pharmacologie, Exemestane, chemistry.chemical_compound, Receptors, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Clinical endpoint, Pharmacology (medical), Androstadienes -- administration & dosage, Receptors, Progesterone -- metabolism, General Clinical Medicine, Progesterone, Original Research, Cancer, Medicine(all), Aged, 80 and over, education.field_of_study, Hormone receptor positive, Breast Neoplasms -- drug therapy -- metabolism -- pathology, Liver Neoplasms, Liver Neoplasms -- drug therapy -- secondary, Progression-free survival, Pharmacology and Pharmaceutical Sciences, General Medicine, Sciences bio-médicales et agricoles, Middle Aged, Postmenopause, Treatment Outcome, Receptors, Estrogen, 6.1 Pharmaceuticals, Receptors, Estrogen -- metabolism, Female, Advanced breast cancer, Postmenopausal, Receptors, Progesterone, medicine.drug, Sirolimus -- administration & dosage -- analogs & derivatives, Adult, medicine.medical_specialty, Clinical Trials and Supportive Activities, Population, Bone Neoplasms, Breast Neoplasms, and over, Antineoplastic Combined Chemotherapy Protocols -- therapeutic use, Disease-Free Survival, Breast cancer, Double-Blind Method, Clinical Research, Internal medicine, Breast Cancer, medicine, Adjuvant therapy, Humans, Everolimus, education, Aged, Bone Neoplasms -- drug therapy -- secondary, Sirolimus, Gynecology, Lung Neoplasms -- drug therapy -- secondary, business.industry, Evaluation of treatments and therapeutic interventions, Interim analysis, medicine.disease, Estrogen, Androstadienes, chemistry, business

    وصف الملف: 1 full-text file(s): application/pdf; application/pdf

  8. 8

    المصدر: Vestbo, J, Anderson, J, Brook, R D, Calverley, P M, Celli, B R, Crim, C, Haumann, B, Martinez, F, Yates, J & Newby, D E 2013, ' The study to understand mortality and morbidity in COPD (SUMMIT) study protocol ', European Respiratory Journal, vol. 41, no. 5, pp. 1017-1022 . https://doi.org/10.1183/09031936.00087312

  9. 9

    المصدر: European journal of cancer, 49 (12

    وصف الملف: 1 full-text file(s): application/pdf

  10. 10

    المصدر: Annals of oncology : official journal of the European Society for Medical Oncology. 19(5)

    مصطلحات موضوعية: Oncology, Neoplasms, Hormone-Dependent/drug therapy/surgery, medicine.medical_treatment, Cyclophosphamide/administration & dosage, Tamoxifen/administration & dosage, Chemotherapy, Adjuvant, Antineoplastic Combined Chemotherapy Protocols, Granulocyte Colony-Stimulating Factor, Methotrexate/administration & dosage, Mastectomy, Cumulative dose, Peripheral Nervous System Diseases, Combination chemotherapy, Neoplasms, Second Primary, Hematology, Middle Aged, Chemotherapy regimen, Combined Modality Therapy, Carcinoma/*drug therapy/radiotherapy/secondary/surgery, Fluorouracil/administration & dosage, Lymphatic Metastasis, Breast Neoplasms/*drug therapy/radiotherapy/surgery, Female, Fluorouracil, effects/*therapeutic use, Epirubicin, medicine.drug, Adult, medicine.medical_specialty, Neoplasms, Hormone-Dependent, Paclitaxel/administration & dosage/adverse effects, Paclitaxel, Peripheral Nervous System Diseases/chemically induced, Epirubicin/administration & dosage, Breast Neoplasms, Breast cancer, Granulocyte Colony-Stimulating Factor/therapeutic use, Internal medicine, medicine, Antineoplastic Combined Chemotherapy Protocols/administration & dosage/adverse, Humans, Androstadienes/administration & dosage, Cyclophosphamide, Aged, Chemotherapy, Dose-Response Relationship, Drug, business.industry, Carcinoma, Estrogens, medicine.disease, Hematologic Diseases, Androstadienes, Regimen, Tamoxifen, Hematologic Diseases/chemically induced, Methotrexate, Neoplasms, Second Primary/epidemiology, business, Febrile neutropenia